Journal of Hematology & Thromboembolic Diseases

Journal of Hematology & Thromboembolic Diseases
Open Access

ISSN: 2329-8790

+44 1478 350008

Siti Asmaa Mat Jusoh

Publications
  • Research Article
    Restoration of PRG2 Expression by 5-Azacytidine Involves in Sensitivity of PKC-412 (Midostaurin) Resistant FLT3-ITD Positive Acute Myeloid Leukaemia Cells
    Author(s): Hamid Ali Nagi Al-jamal, Siti Asmaa Mat Jusoh, Mohamad Ros Sidek, Rosline Hassan and Muhammad Farid JohanHamid Ali Nagi Al-jamal, Siti Asmaa Mat Jusoh, Mohamad Ros Sidek, Rosline Hassan and Muhammad Farid Johan

    Background: Tumor-suppressor genes Tumour suppressor genes (TSG) are inactivated by methylation in several cancers including acute myeloid leukemia (AML). Transcriptional silencing of PRG2 gene could be involved in development and progression of cancers. 5-Azacytidine (5-Aza) is a DNA methyltransferase inhibitor that causes DNA de-methylation resulting in re-expression of silenced TSG. Midostaurin (PKC412) is a multitargeted tyrosine kinase inhibitor that potently inhibits FLT3 tyrosine kinase and induces hematological remission in patients with AML. However, majority of AML patients in clinical trials developed resistance to PKC412. Methods: Resistant cells were developed by overexposure of MV4-11 cells to PKC-412 and treated with 5-Aza. Apoptosis and cytotoxicity of PKC-412 were determined using Annexin V and MTS assays, respectively. Gene.. View More»
    DOI: 10.4172/2329-8790.1000186

    Abstract PDF

Relevant Topics

Top